Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092306025> ?p ?o ?g. }
- W2092306025 endingPage "126" @default.
- W2092306025 startingPage "102" @default.
- W2092306025 abstract "Breast cancer remains the second leading cause of cancer death despite numerous advances in medical science. In vitro, preclinical, and clinical trials have shown that chemotherapy dose intensity is an important component of therapy. Many clinical trials addressing the use of high-dose chemotherapy and hematopoietic cellular rescue have been conducted over the past decade. Early trials undertaken in heavily pretreated patients who had metastatic disease were associated with high treatment-related mortality rates; good response rates were noted but overall survivals were short. Subsequent technological advances, including the use of recombinant hematopoietic growth factors and peripheral blood progenitor cells as the source of cellular rescue, have dramatically lowered the morbidity and mortality of the procedure, as well as shortened hospital stay and markedly reduced cost. As a result, the high-dose chemotherapy approach has been used earlier in the disease course, both in patients with metastatic disease who were responding and in the adjuvant setting in patients at high risk for relapse. Results of many of these phase II trials are extremely encouraging, and phase III prospective, randomized trials comparing autotransplant to conventional approaches are currently under way. This review discusses past, current, and future initiatives of this modality. Included is a discussion of new preparative regimens, the addition of agents such as biochemical modifiers to enhance antitumor activity, and issues regarding timing of autotransplant, stem cell technology, use of allogeneic stem cells, and posttransplantation therapies." @default.
- W2092306025 created "2016-06-24" @default.
- W2092306025 creator A5042915360 @default.
- W2092306025 date "1998-01-01" @default.
- W2092306025 modified "2023-09-26" @default.
- W2092306025 title "Clinical Trial: Hematopoietic Progenitor Cell Transplantation in Breast Cancer: Current Status and Future Directions" @default.
- W2092306025 cites W104752687 @default.
- W2092306025 cites W152073719 @default.
- W2092306025 cites W1522048276 @default.
- W2092306025 cites W1565345042 @default.
- W2092306025 cites W1570247268 @default.
- W2092306025 cites W16036224 @default.
- W2092306025 cites W1723772693 @default.
- W2092306025 cites W1748734394 @default.
- W2092306025 cites W1754349841 @default.
- W2092306025 cites W1783920313 @default.
- W2092306025 cites W1785581158 @default.
- W2092306025 cites W1813712453 @default.
- W2092306025 cites W1823011883 @default.
- W2092306025 cites W1824148142 @default.
- W2092306025 cites W1840779962 @default.
- W2092306025 cites W1842248410 @default.
- W2092306025 cites W1843077828 @default.
- W2092306025 cites W1846857303 @default.
- W2092306025 cites W1849177728 @default.
- W2092306025 cites W1852147417 @default.
- W2092306025 cites W1859960333 @default.
- W2092306025 cites W1861752845 @default.
- W2092306025 cites W1863232834 @default.
- W2092306025 cites W1872096120 @default.
- W2092306025 cites W1877303819 @default.
- W2092306025 cites W1881816600 @default.
- W2092306025 cites W1889677868 @default.
- W2092306025 cites W1892191215 @default.
- W2092306025 cites W1899541887 @default.
- W2092306025 cites W1900945709 @default.
- W2092306025 cites W190201512 @default.
- W2092306025 cites W1919838648 @default.
- W2092306025 cites W1926402633 @default.
- W2092306025 cites W1929549982 @default.
- W2092306025 cites W1936035002 @default.
- W2092306025 cites W1937538988 @default.
- W2092306025 cites W1938930090 @default.
- W2092306025 cites W1942361359 @default.
- W2092306025 cites W1943279816 @default.
- W2092306025 cites W1964048141 @default.
- W2092306025 cites W1964086138 @default.
- W2092306025 cites W1967409362 @default.
- W2092306025 cites W1967693784 @default.
- W2092306025 cites W1968965382 @default.
- W2092306025 cites W1969008635 @default.
- W2092306025 cites W1969150881 @default.
- W2092306025 cites W1971843076 @default.
- W2092306025 cites W1972637700 @default.
- W2092306025 cites W1972925117 @default.
- W2092306025 cites W1975020079 @default.
- W2092306025 cites W1975285483 @default.
- W2092306025 cites W1975829266 @default.
- W2092306025 cites W1977404622 @default.
- W2092306025 cites W1979087549 @default.
- W2092306025 cites W1988877375 @default.
- W2092306025 cites W1989367285 @default.
- W2092306025 cites W1989946391 @default.
- W2092306025 cites W1990049671 @default.
- W2092306025 cites W1995437819 @default.
- W2092306025 cites W1997353354 @default.
- W2092306025 cites W1998207473 @default.
- W2092306025 cites W2002031476 @default.
- W2092306025 cites W2005068607 @default.
- W2092306025 cites W2005230066 @default.
- W2092306025 cites W2006174096 @default.
- W2092306025 cites W2007001439 @default.
- W2092306025 cites W2007279899 @default.
- W2092306025 cites W2007353700 @default.
- W2092306025 cites W2011292580 @default.
- W2092306025 cites W2012213361 @default.
- W2092306025 cites W2012605723 @default.
- W2092306025 cites W2013472456 @default.
- W2092306025 cites W2016751107 @default.
- W2092306025 cites W2018452925 @default.
- W2092306025 cites W2021380096 @default.
- W2092306025 cites W2022174214 @default.
- W2092306025 cites W2026618405 @default.
- W2092306025 cites W2028301502 @default.
- W2092306025 cites W2028326134 @default.
- W2092306025 cites W2028356422 @default.
- W2092306025 cites W2028787200 @default.
- W2092306025 cites W2030129022 @default.
- W2092306025 cites W2030312997 @default.
- W2092306025 cites W2032590752 @default.
- W2092306025 cites W2033442994 @default.
- W2092306025 cites W2033546635 @default.
- W2092306025 cites W2035357902 @default.
- W2092306025 cites W2036067444 @default.
- W2092306025 cites W2037172440 @default.
- W2092306025 cites W2037971824 @default.
- W2092306025 cites W2038252831 @default.
- W2092306025 cites W2043297474 @default.